Residence USA Name Douglas Richman | Fields Virology | |
Institutions University of California, San Diego Veterans Affairs San Diego Health System Known for HIV resistance, HIV latency Education Stanford University (1970), Dartmouth College Awards Guggenheim Fellowship for Natural Sciences, US & Canada | ||
Douglas D. Richman (born 15 February 1943, New York, NY) is an American medical virologist. Richman has worked primarily in the HIV field over the past twenty years, with major contributions in the areas of resistance and pathogenicity.
Contents
Career
Richman received his MD degree from Stanford University in 1970. After holding positions at the U.S. Public Health Service, National Institute of Allergy and Infectious Diseases and Harvard Medical School, he joined the University of California, San Diego (UCSD) in 1976, becoming Professor of Pathology and Medicine (1988) as well as Co-Director (1994) and later Director (2000) of the Center for AIDS Research. As of 2007, he additionally holds the Florence Seeley Riford Chair in AIDS Research there.
He has also held positions at the Veterans Affairs San Diego Health System since 1976, including Director from 1988 to 2007. As of 2007, he holds the position of staff physician.
Research
Richman's early research was on influenza virus, herpesviruses and hemorrhagic fever viruses, before focusing on HIV in the 1980s. His wide-ranging research in the HIV field has encompassed resistance, viral pathogenicity and host immune responses. He was one of the group of researchers who first demonstrated HIV drug resistance in 1989, and in 1997, his laboratory was also among the first to demonstrate HIV latency.
As of 2007, his HIV/AIDS research focuses on the natural history and molecular pathogenesis of acute HIV infection, particularly the immune responses to the virus, and viral evolution to evade the immune system.
Awards, editorships and advisory positions
Awards include the Howard M. Temin Award (1993), Steve Chase Humanitarian Award for Science and Medicine of the Desert AIDS Project (2001) and United States Department of Veterans Affairs Middleton Award (2002).
Richman is one of the founding editors of the academic journal Antiviral Therapy , a founding volunteer member of the [[International Antiviral (formerly AIDS) Society-USA (IAS-USA) Board of Directors, and is Editor-in-Chief of Topics in HIV Medicine, as well as having served on the editorial board of 15 journals. He is a co-editor of the textbook Clinical Virology and editor of Antiviral Drug Resistance. He serves on the Vaccine Research Committee of the AIDS Clinical Trials Group and IAS-USA expert panel responsible for publishing international HIV treatment and drug resistance testing guidelines. He is the founding chair of the IAS-USA Antiretroviral Drug Resistance Mutations Listing, which is the worldwide standard for designating mutations that impact susceptibility to treatment